Siemens Biomarker Multi-modality
Recruiting
N/A
Interventional Study
Fatty Liver
Hepatic Steatosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 45 (estimated)
- Sponsor
- Duke University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to see how well Photon Counting CT (PCCT) and ultrasound test results can find fat and scarring in the liver. They will be compared to MRI test results as the reference standard. Participants will get a regular CT scan on the PCCT scanner, plus a few extra pictures just for the study. They will also get an MRI, either on the same day or a different day, whichever is pr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age of 18 years or older
* Has clinically indicated CT schedule including the liver (with contrast or with and without contrast)
* Patient eligible for MR imaging
* History of chronic diffuse liver disease, steatotic liver disease, and/ or liver fibrosis
* Capable of consent
…
Contacts